Trials / Completed
CompletedNCT02930668
Efficacy and Safety of Glucosanol™ in Body Weight Reduction
Double-blind, Randomised, Placebo-controlled Study to Evaluate Benefit of Glucosanol™ in Reducing Body Weight in Overweight and Moderately Obese Subjects
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 90 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
It was proven in a previous clinical study that Glucosanol™ is effective and safe in reducing weight in the overweight and obese. The present study aims at expanding the data concerning the weight management effect of Glucosanol™ in overweight and moderately obese population.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Glucosanol 350mg | |
| DIETARY_SUPPLEMENT | Glucosanol 500mg | |
| DIETARY_SUPPLEMENT | Placebo |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-11-01
- Completion
- 2016-11-01
- First posted
- 2016-10-12
- Last updated
- 2023-07-27
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT02930668. Inclusion in this directory is not an endorsement.